Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
biospace.com > press-releases > prasco-increases-pharmaceutical-footprint-in-ohio

Prasco Increases Pharmaceutical Footprint in Ohio

3+ hour, 37+ min ago   (188+ words) BioSpace Prasco Increases Pharmaceutical Footprint in Ohio MASON, Ohio, Aug. 31, 2026 /PRNewswire/ -- Prasco, LLC, a leading pharmaceutical commercialization company specializing in Authorized Generics with over 65 brand partners worldwide, today announced the acquisition of a strategically located distribution facility in Carey, Ohio....

BioSpace
biospace.com > press-releases > connie-health-announces-acquisition-of-clearlink-insurance-agency-and-series-b-funding-to-accelerate-growth-in-medicare

Connie Health Announces Acquisition of Clearlink Insurance Agency and Series B Funding to Accelerate Growth in Medicare

2+ mon, 1+ week ago   (490+ words) BioSpace Connie Health Announces Acquisition of Clearlink Insurance Agency and Series B Funding to Accelerate Growth in Medicare BOSTON, June 18, 2026 /PRNewswire/ -- Connie Health, the nation's leading AI-native Medicare navigation platform, today announced the completion of its acquisition and integration of…...

Google News
biospace.com > press-releases > kaiser-permanente-names-emily-holliman-president-of-mid-atlantic-states-region

Kaiser Permanente names Emily Holliman president of Mid-Atlantic States region

2+ mon, 3+ week ago   (214+ words) Holliman previously served as interim president of the market. Prior to joining Kaiser Permanente, Holliman served in senior leadership roles at other hospitals and health organizations nationwide. She was market vice president for Ardent Health Services' New Jersey market; CEO…...

BioSpace
biospace.com > press-releases > contraline-announces-92-5-million-series-b-financing-to-advance-nes-t-male-contraceptive-into-late-stage-development

Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development

2+ mon, 4+ week ago   (261+ words) NES/T recently completed a global Phase 2b clinical trial enrolling 462 couples and demonstrated encouraging efficacy, tolerability, reversibility, and user acceptability. The company anticipates initiating Phase 3 clinical development in 2027. “This financing enables Contraline to advance NES/T through Phase 3 development and…...

BioSpace
biospace.com > policy > regeneron-finally-joins-trumps-drug-pricing-push-while-notching-landmark-approval

Regeneron finally joins Trump’s drug pricing push while notching landmark approval

4+ mon, 6+ day ago   (411+ words) After nearly nine months of holding out, Regeneron has finally agreed to fall in line with the Trump administration’s Most Favored Nation pricing push. Thursday evening, just hours after announcing the FDA approval for its hearing loss gene therapy Otarmeni,…...

BioSpace
biospace.com > business > trump-hits-drugmakers-with-100-tariff-but-carve-outs-soften-the-blow

Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow

4+ mon, 3+ week ago   (523+ words) The Trump administration has imposed a 100% tariff on imports of patented pharmaceutical products and ingredients. However, analysts predicted the action will have a limited effect on many companies. One year after proposing its “Liberation Day” tariffs, the Trump administration has…...

BioSpace
biospace.com > business > trumps-mfn-pricing-expected-to-delay-more-european-drug-launches

Trump’s MFN Pricing Expected To Delay More European Drug Launches

4+ mon, 4+ week ago   (485+ words) Companies have questioned whether they can limit launches to the markets where they can charge the most to avoid eroding U.S. prices, Majewski explained. However, that approach has a flaw. As Eva Marchese, vice president at CRA, told BioSpace, a new…...

BioSpace
biospace.com > press-releases > pfizer-launches-cost-savings-program-on-trumprx-lowering-drug-costs-for-millions-of-americans

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

6+ mon, 3+ week ago   (567+ words) BioSpace Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans - Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more - Affirms Pfizer’s commitment to reduce drug costs for millions…...

BioSpace
biospace.com > policy > trumprx-delayed-amid-potential-anti-kickback-concerns

TrumpRx Delayed Amid Potential Anti-Kickback Concerns

7+ mon, 1+ day ago   (369+ words) Flickr, White House/Daniel Torok The White House has delayed the launch of TrumpRx, the federal government’s proposed marketplace that will allow patients to purchase their medicines directly from pharma companies. “In any other administration, it would 100 percent be the…...

BioSpace
biospace.com > policy > acadia-ceo-bands-with-peers-to-lobby-against-mfn-drug-pricing-for-small-biotech

Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech

7+ mon, 2+ week ago   (771+ words) Acadia CEO Catherine Owen Adams, After a year of watching major pharma companies in the Trump administration’s hot seat for drug pricing, Acadia Pharmaceuticals CEO Catherine Owen Adams isn’t taking any chances. The CEO is one of the founders of…...